🔗 Share this article

A shadow market for unapproved weight-loss drugs is propelled by social media fitness personalities and vendors on messaging platforms, based on new investigations.

Investigational Drug Acquiring Traction Via Social Media

Retatrutide, which remains in clinical trials, is being promoted by social media influencers for its alleged fat-burning properties. Viewers are urged to contact these accounts privately for supplier links, while also obtaining discount codes.

Thriving Trade on Messaging Platforms

Separately, a robust market exists on Telegram, where communities with numerous of members share “before and after” images, injection guides and claims of next-day UK delivery. Vendors market the substance there before redirecting buyers to WhatsApp for purchases.

Understanding The Experimental Drug

This medication is an experimental injection created by American pharmaceutical company Eli Lilly. The drug targets three gut hormones – GLP-1, GIP and glucagon. Preliminary studies indicate it could help individuals reduce up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being promoted digitally as the next Ozempic.

Medical Experts Voice Concerns

However, physicians and pharmacists have warned that the distribution of what is still an unapproved drug in the UK is worrisome and could lead to individuals administering products of uncertain source.

Several experts stated the popularity for the experimental drug could be connected to the increasing cost of approved weight loss products such as Mounjaro.

Regulatory Position and Enforcement

Marketing the unapproved drug on social media or messaging apps is illegal in the UK, as it is an unlicensed medication that must not be promoted or distributed for human use under the Human Medicines Regulations 2012.

Several influencers try to circumvent the regulations by calling to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled substance, but advertising and distribution can still violate medicines, advertising, and consumer laws, potentially leading to penalties, legal action or imprisonment.

Service Reaction and Content Removal

According to TikTok, the service has removed violative material and prohibited associated hashtags and query recommendations. The company stated it was dedicated to maintaining the platform safe and allocating resources in enhancing compliance measures.

Digital Trading Operations

Research also found communities with up to 9,000 members selling the experimental drug using the platform's integrated discovery tool, which operates like a online catalog. Entering “retatrutide” immediately brings up groups with thousands of members, populated with images of weight loss, glowing reviews and step-by-step instructions for mixing or administering at home.

Within moments of joining one group, a seller shared WhatsApp details, where most purchases occur. The vendor provided an guidebook and promised shipping within two days. When questioned whether the product was genuine, one vendor said: “You can’t be sure.” Another shared a photo of a alleged laboratory certificate. None inquired about body mass, medical conditions or previous experience.

Item Information and Pricing

Inside these groups, posts display dark colored parcels with Royal Mail stickers, claiming to contain fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, prepared at home with sterile water, or ready-to-use injectors usually priced at 160 pounds for 20mg. When questioned how long a pen should last, vendors give contradictory answers ranging from a several days to “depends on your body”.

Service Moderation and Safety Actions

A representative for the messaging service said it regularly monitored dangerous content on its service including content that promoted the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“People are injecting substances they cannot confirm. Although the research behind retatrutide is valid, these online products may not contain what they claim,” said Jason Murphy, the director of pharmaceutical services at Chemist4U.

A medical professional of an online medical service connected the increase in interest to current cost increases for authorized slimming drugs such as Mounjaro. “With costs increasing, individuals are using social media. But counterfeit treatments are highly risky. You can’t be certain what’s inside or whether the conditions they were made in was clean,” she explained.

Her staff has already seen individuals injured by self-injection from unverified suppliers. “We understand the disappointment, but buying from messaging apps or WhatsApp is taking chances with your well-being,” said the doctor. “These substances could be impure or improperly measured.”

Producer Statement

A representative from the pharmaceutical company said the substance was in third stage clinical trials and had not been evaluated or authorized by any government authority globally. “Therefore at this time no one can market [it] for personal consumption,” they explained, adding that any product “misleadingly claiming itself as a company investigational substance not yet approved … may subject users to possibly serious medical dangers”.